KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly
The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace
The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace
A look at why investors should stock up on Amgen, Celldex Therapeutics, and Novavax soon. Source: BioSpace
FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace
Agreement covers employees who agree to leave voluntarily. Source: BioSpace
Takeda CEO Christophe Weber is sticking to his game plan of actively hunting deals that will expand its global presence and create a stronger international profile. Source: BioSpace
Kala Pharma released mostly positive topline results from two Phase III clinical trials for KPI-121 in patients with dry eye disease. Source: BioSpace
Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion. Source: BioSpace
The additional capital is expected to provide funding to advance avacopan through topline data from the Phase III ADVOCATE trial as well as potential registration filings in the U.S. and…
The Series A round was entirely funded by founding investor Apple Tree Partners. Source: BioSpace
Dr. Lammers brings more than 27 years of experience in product and clinical development spanning the pharmaceutical and biotechnology industries. Source: BioSpace